Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1774-1782

  Ray, Bimal K ^a,b   Shakya, Arvind ^a   Ray, Alpana ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; SERUM AMYLOID A; SERUM AMYLOID A ACTIVATING FACTOR 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CANCER; CARTILAGE CELL; CELL INFILTRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SYNOVITIS; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

EID: 33846557561     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1774     Document Type: Article

References (39)

1. Ferrara, N., and H. P. Gerber. 2001. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 106: 148-156.
2. Haywood, L., D. F. McWilliams, C. I. Pearson, S. E. Gill, A. Ganesan, D. Wilson, and D. A. Walsh. 2003. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 48: 2173-2177.
3. Goldring, M. B. 1999. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect. Tissue Res. 40: 1-11.
4. Pufe, T., V. Harde, W. Petersen, M. B. Goldring, B. Tillmann, and R. Mentlein. 2004. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J. Pathol. 202: 367-374.
5. Pfander, D., D. Kortje, R. Zimmermann, G. Weseloh, T. Kirsch, M. Gesslein, T. Cramer, and B. Swoboda. 2001. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann. Rheum. Dis. 60: 1070-1073.
6. Koch, A. E., L. A. Harlow, G. K. Haines, E. P. Amento, E. N. Unemori, W. L. Wong, R. M. Pope, and N. Ferrara. 1994. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 52: 4149-4156.
7. Fava, R. A., N. J. Olsen, G. Spencer-Green, K. T. Yeo, T. K. Yeo, B. Berse, R. W. Jackman, D. R. Senger, H. F. Dvorak, and L. F. Brown. 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180: 341-346.
8. Pertovaara, L., A. Kaipainen, T. Mustonen, A. Orpana, N. Ferrara, O. Saksela, and K. Alitalo. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem. 269: 6271-6274.
9. Forsythe, J. A., B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, and G. L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16: 4604-4613.
10. Levy, A. P., N. S. Levy, S. Wegner, and M. A. Goldberg. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333-13340.
11. Schipani, E., H. E. Ryan, S. Didrickson, T. Kobayashi, M. Knight, and R. S. Johnson. 2001. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev. 15: 2865-2876.
12. Kiriakidis, S., E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog. 2003. VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor κBα and a kinase-defective form of the IκB kinase 2. J. Cell Sci. 116: 665-674.
13. Pore, N., S. Liu, H. K. Shu, B. Li, D. Haas-Kogan, D. Stokoe, J. Milanini-Mongiat, G. Pages, D. M. O'Rourke, E. Bernhard, and A. Maity. 2004. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell 15: 4841-4853.
14. Gille, J., R. A. Swerlick, and S. W. Caughman. 1997. Transforming growth factor-α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J. 16: 750-759.
15. Mueller, M. D., J. L. Vigne, A. Minchenko, D. I. Lebovic, D. C. Leitman, and R. N. Taylor. 2000. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc. Natl. Acad. Sci. USA 97: 10972-10977.
16. Ray, A., and B. K. Ray. 1998. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter. Mol. Cell. Biol. 18: 7327-7335.
17. Ray, A., D. Kumar, A. Shakya, C. R. Brown, J. L. Cook, and B. K. Ray. 2004. Serum amyloid A-activating factor-1 transgenic mice are prone to develop a severe form of inflammation-induced arthritis. J. Immunol. 173: 4684-4691.
18. Ray, A., K. Kuroki, J. L. Cook, B. S. Bal, K. Renter, G. Aust, and B. K. Ray. 2003. Induction of matrix metalloproteinase 1 gene expression is regulated by inflammation-responsive transcription factor SAF-1 in osteoarthritis. Arthritis Rheum. 48: 134-145.
19. Ray, A., B. S. Bal, and B. K. Ray. 2005. Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1. J. Immunol. 175: 4039-4048.
20. Ray, B. K., A. Shakya, J. R. Turk, S. S. Apte, and A. Ray. 2004. Induction of the MMP-14 gene in macrophages of the atherosclerotic plaque: role of SAF-1 in the induction process. Circ. Res. 95: 1082-1090.
21. Outerbridge, R. E. 1961. The etiology of chondromalacia patellae. J. Bone Joint Surg. Br. 43: 752-757.
22. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes, and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266: 11947-11954.
23. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Adds Res. 15: 5490-5490.
24. Chaqour, B., R. Yang, and Q. Sha. 2006. Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-κB activation. J. Biol. Chem. 281: 20608-20622.
25. Ray, A., D. Kumar, P. Ray, and B. K. Ray. 2004. Transcriptional activity of SAF-1 is regulated by distinct functional modules. J. Biol. Chem. 279: 54637-54646.
26. Ray, A., and B. K. Ray. 1993. Analysis of the promoter element of the serum amyloid A gene and its interaction with constitutive and inducible nuclear factors from rabbit liver. Gene Exp. 3: 151-162.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
28. Ray, B. K., and A. Ray. 1997. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 36: 4662-4668.
29. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
30. Ben-Av, P., L. J. Crofford, R. L. Wilder, and T. Hla. 1995. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372: 83-87.
31. Berse, B., J. A. Hunt, R. J. Diegel, P. Morganelli, K. Yeo, F. Brown, and R. A. Fava. 1999. Hypoxia augments cytokine (TGF-β and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin. Exp. Immunol. 115: 176-182.
32. Levy, A. P., N. S. Levy, and M. A. Goldberg. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271: 2746-2753.
33. Detmar, M., L. F. Brown, K. P. Claffey, K. T. Yeo, O. Kocher, R. W. Jackman, B. Berse, and H. F. Dvorak. 1994. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180: 1141-1146.
34. Grugel, S., G. Finkenzeller, K. Weindel, B. Barleon, and D. Marme. 1995. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270: 25915-25919.
35. Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48: 79-89.
36. Ray, A., H. Schatten, and B. K. Ray. 1999. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J. Biol. Chem. 274: 4300-4308.
37. Song, J., H. Ugai, H. Nakata-Tsutsui, S. Kishikawa, E. Suzuki, T. Murata, and K. K. Yokoyama. 2003. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements. Int. J. Mol. Med. 11: 547-553.
38. Greenberg, N. M., F. DeMayo, M. J. Finegold, D. Medina, W. D. Tilley, J. O. Aspinall, G. R. Cunha, A. A. Donjacour, R. J. Matusik, and J. M. Rosen. 1995. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92: 3439-3443.
39. Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65: 499-560.